Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Sarcoma 1Lymphoid 1Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Breast Neoplasms 60Brain Neoplasms 4Meningeal Carcinomatosis 3Meningeal Neoplasms 2Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Ovarian Neoplasms 1Neutropenia 1Neoplasms 1Neoplasm Metastasis 1Inflammatory Breast Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Central Nervous System Neoplasms 1Breast Cancer Organoids 1Breast Cancer Female 1

Interventions

Cyclophosphamide 3Pyridoxine 2Amifostine 2trastuzumab deruxtecan 1sodium thiosulfate 1sargramostim 1sacituzumab govitecan 1eribulin 1Triptorelin Pamoate 1Trastuzumab 1Thiotepa 1Social Determinants of Health 1Radiotherapy 1Pregabalin 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Methotrexate 1Furosemide 1Etoposide 1Epoetin Alfa 1Duloxetine Hydrochloride 1Drug Therapy 1Doxorubicin 1Dihydrouracil Dehydrogenase (NADP) 1Cisplatin 1Chemotherapy, Adjuvant 1Celecoxib 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Methotrexate × Breast × Clear all
NCT00397501 2017-04-21

BBBD Followed By Methotrexate and Carboplatin With or Without Trastuzumab in Treating Women With Breast Cancer That Has Spread to the Brain

OHSU Knight Cancer Institute

Phase 1/2 Withdrawn
BreastCNS

Brain Neoplasms, Breast Neoplasms, Central Nervous System Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡